EA
PFE icon

Emerald Acquisition’s Pfizer PFE Stock Holding History

Emerald Acquisition’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		$450M Sell
14,008,623
-2,613,333
-16% -$87.4M 0.87% 10
2016
Q2 		$555M Buy
+16,621,956
New +$530M 0.96% 5

Other funds holding PFE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Emerald Acquisition's PFE Position: Q3 2016 in Review

Emerald Acquisition reduced its Pfizer (PFE) stake by 16% in Q3 2016, selling an estimated $87.4M and leaving 14,008,623 shares worth $450M. The position accounts for 0.87% of the portfolio, ranked #10.

Emerald Acquisition first reported a position in PFE in Q2 2016 and has held it in 2 quarters since. The position peaked at $555M in Q2 2016. 1,962 funds tracked by Wall St. Rank hold PFE as of Q3 2016.

  • Emerald Acquisition held 14,008,623 shares of Pfizer worth $450M as of Q3 2016.
  • Emerald Acquisition sold 2,613,333 Pfizer shares in Q3 2016, an estimated $87.4M.
  • Pfizer made up 0.87% of Emerald Acquisition's portfolio in Q3 2016, its #10 holding.
  • Emerald Acquisition first reported a position in Pfizer in Q2 2016 and has held it in 2 quarters since.
  • Emerald Acquisition's Pfizer position peaked at $555M in Q2 2016.
  • 1,962 funds tracked by Wall St. Rank held Pfizer as of Q3 2016.

Based on Emerald Acquisition's 13F filing for Q3 2016, filed 9 Nov 2016.